Virtu Financial LLC acquired a new stake in shares of Clearmind Medicine Inc. (NASDAQ:CMND – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 39,479 shares of the company’s stock, valued at approximately $54,000. Virtu Financial LLC owned about 0.92% of Clearmind Medicine at the end of the most recent reporting period.
Clearmind Medicine Trading Down 3.3 %
Clearmind Medicine stock opened at $1.04 on Tuesday. Clearmind Medicine Inc. has a 52-week low of $0.95 and a 52-week high of $2.30. The company has a market cap of $4.41 million, a P/E ratio of -0.55 and a beta of 1.02. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. The business has a 50-day simple moving average of $1.26 and a two-hundred day simple moving average of $1.34.
Clearmind Medicine (NASDAQ:CMND – Get Free Report) last issued its quarterly earnings data on Thursday, March 13th. The company reported ($0.24) earnings per share (EPS) for the quarter.
Clearmind Medicine Profile
Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.
See Also
- Five stocks we like better than Clearmind Medicine
- What Are Dividend Achievers? An Introduction
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is the Nikkei 225 index?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Bank Stocks – Best Bank Stocks to Invest In
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding CMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clearmind Medicine Inc. (NASDAQ:CMND – Free Report).
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.